AGING AND HUMAN HORMONAL AND PRESSOR RESPONSIVENESS TO ANGIOTENSIN-II INFUSION WITH SIMULTANEOUS MEASUREMENT OF EXOGENOUS AND ENDOGENOUS ANGIOTENSIN-II

被引:26
|
作者
DUGGAN, J
NUSSBERGER, J
KILFEATHER, S
OMALLEY, K
机构
[1] Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin
[2] Division of Hypertension, University Hospital, Lausanne
关键词
AGE; ANGIOTENSIN-II INFUSION; BLOOD PRESSURE; ALDOSTERONE; HPLC; RADIOIMMUNOASSAY; PLATELET ANGIOTENSIN-II RECEPTOR DENSITY; ASN(1); VAL(5)-ANGIOTENSIN-II (HYPERTENSIN);
D O I
10.1093/ajh/6.8.641
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
A decline in the function of the renin angiotensin aldosterone system may induce adaptive changes in response to angiotensin II (ANG II) with age. We have examined platelet ANG II receptor density, blood pressure and aldosterone responses to ANG II [Asn1, Val5-ANG II] (Hypertensin, Ciba Geigy, Horsham, Sussex, England) infusion in 8 young, 24 to 30 years, and 8 older, 54 to 65 years, healthy volunteers. To measure circulating ANG II, we established a new method for specific and simultaneous measurement of exogenous [Asn1, Val5] (Hypertensin) and endogenous [Asp1, Ile-5] ANG II in plasma by using isocratic HPLC and radioimmunoassays with cross-reacting antibodies and compared results with immunoreactive ANG II which was measured conventionally using monoclonal antibodies. Baseline endogenous ANG II (Asp1, Ile-5-ANG II) levels in venous plasma were marginally, but not significantly, lower in the old [mean (95% confidence limits): 3.4 (< 0.1 to 7.7) v 3.7 (1.2 to 6.2), fmol/mL] and during suppression by the Hypertensin infusion appeared consistently, but not significantly, lower in the old [0.9 (0 to 3.1) v 2.1 (0.6 to 3.7), after 3 ng/kg/min], while the same infusion rate in young and old resulted in similar plasma Hypertensin levels. Baseline systolic blood pressure (SBP) was similar in both groups but the percentage increases in SBP at infusion rates of 1, 3.0, and 10 ng/kg/min were greater in the old than in the young (9.1 v 2.8, P < .05; 16.3 v 8.0, P < .01; 30.4 v 14.0% P < .001, respectively). The increment in diastolic blood pressure or mean arterial pressure during infusion did not differ significantly between the groups. Heart rate fell significantly during ANG II infusion in young (P < .05) but not old subjects. Basal plasma aldosterone was similar in both groups. However, the percentage increases in plasma aldosterone were greater in young than old at infusion rates of 1.0, 3.0, and 10.0 ng/kg/min (94 v - 5, 238 v 28; 462 v 69%, all P < .001). Platelet ANG II receptor density was elevated in the old [6.5 (1.9 to 11.1) v 1.14 (0.21 to 2.07), fmol/10(9) cells, P < .01]. Our findings demonstrate that it is possible to measure specifically and simultaneously exogenous and endogenous ANG II in plasma during Hypertensin infusion and that endogenous ANG II concentrations decrease with increasing levels of exogenous ANG II. During infusion, similar plasma Hypertensin levels were attained in both young and old, but systolic blood pressure responsiveness was increased in the old, while adrenal responsiveness was reduced.
引用
收藏
页码:641 / 647
页数:7
相关论文
共 50 条
  • [21] INDOMETHACIN AND ANGIOTENSIN-II PRESSOR RESPONSIVENESS - IMPORTANCE OF DIETARY-SODIUM
    SMYTH, DD
    FUNG, HYM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 102 (01) : 55 - 61
  • [22] MEASUREMENT OF PLASMA ANGIOTENSIN-II
    MORTON, JJ
    WEBB, DJ
    CLINICAL SCIENCE, 1985, 68 (04) : 483 - 484
  • [23] MEASUREMENT OF INTRARENAL ANGIOTENSIN-II
    MENDELSOHN, FAO
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1977, 7 (06): : 678 - 679
  • [24] ANGIOTENSIN-II RECEPTORS AND ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    TIMMERMANS, PBMWM
    WONG, PC
    CHIU, AT
    HERBLIN, WF
    BENFIELD, P
    CARINI, DJ
    LEE, RJ
    WEXLER, RR
    SAYE, JAM
    SMITH, RD
    PHARMACOLOGICAL REVIEWS, 1993, 45 (02) : 205 - 251
  • [25] EFFECTS OF AGING AND HYPERTENSION ON PLASMA ANGIOTENSIN-II AND PLATELET ANGIOTENSIN-II RECEPTOR DENSITY
    DUGGAN, J
    KILFEATHER, S
    OBRIEN, E
    OMALLEY, K
    NUSSBERGER, J
    AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (10) : 687 - 693
  • [26] POTENTIATION OF THE PRESSOR EFFECT OF ANGIOTENSIN-II BY INTRAVENTRICULAR INFUSION OF HYPERTONIC SALINE
    MIKAMI, H
    KATAHIRA, K
    OGIHARA, T
    KOHARA, K
    OTSUKA, A
    KUMAHARA, Y
    AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (03) : S4 - S7
  • [27] SYNTHESIS OF ANGIOTENSIN-II ANALOGS AS SELECTIVE ANTAGONISTS FOR PRESSOR AND ALDOSTERONE-RELEASING EFFECTS OF ANGIOTENSIN-II
    KHOSLA, MC
    SMEBY, RR
    BUMPUS, FM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1975, (169): : 57 - 57
  • [28] CHRONIC INTRACEREBROVENTRICULAR INFUSION OF ANGIOTENSIN-II
    ADDO, MF
    ISOM, GE
    PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY, 1979, 22 : 247 - 249
  • [29] TACHYPHYLAXIS OF PRESSOR-RESPONSE TO ANGIOTENSIN-II
    CHAPMAN, BJ
    MUNDAY, KA
    JOURNAL OF PHYSIOLOGY-LONDON, 1978, 277 (APR): : P78 - P79
  • [30] PRESSOR EFFECT OF ANGIOTENSIN-II IN PREGNANT SHEEP
    BLAIRWEST, JR
    WINTOUR, EM
    SCOGGINS, BA
    COGHLAN, JP
    DENTON, DA
    AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1972, 50 (DEC): : 739 - +